ScholarIQanswers from OpenAlex & ORCID
David P. Ryan
ResearcherPublications, citations & collaboration network
David P. Ryan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David P. Ryan have?
ScholarIQindexed works
David P. Ryan has 931 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David P. Ryan have?
ScholarIQcitation count
David P. Ryan has 35,778 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David P. Ryan?
ScholarIQh-index
David P. Ryan has an h-index of 92 in OpenAlex.
What is the i10-index of David P. Ryan?
ScholarIQi10-index
David P. Ryan has an i10-index of 314 in OpenAlex.
What is the ORCID of David P. Ryan?
ScholarIQorcid
The ORCID for David P. Ryan is on the source record.
What is the OpenAlex record for David P. Ryan?
ScholarIQopenalex
The OpenAlex for David P. Ryan is on the source record.
What are the most-cited papers on David P. Ryan?
ScholarIQmost cited works
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial
Jennifer S. Temel, Joseph A. Greer, Areej El‐Jawahri, William F. Pirl, Elyse R. Park, Vicki A. Jackson, Anthony L. Back, Mihir Kamdar, Juliet Jacobsen, Eva Chittenden, Simone Rinaldi, Emily R. Gallagher, Justin Eusebio, Zhigang Li, Alona Muzikansky, David P. Ryan
Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study
Michael S. Lee, Baek‐Yeol Ryoo, Chih‐Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P. Hack, Jessica Spahn, Bo Liu, Heba Abdullah, Yulei Wang, Aiwu Ruth He, Kyung-Hun Lee, Y-J. Bang, Johanna C. Bendell, Yee Chao, J-S Chen, Hyun Cheol Chung, S. Lindsey Davis, Atul Dev, Edward Gane, Ben George, Aiwu Ruth He, Howard S. Höchster, C-H Hsu, Masafumi Ikeda, Jes Chauviere Lee, M. Lee, Amit Mahipal, Gulam A. Manji, Manabu Morimoto, Kazushi Numata, Michael J. Pishvaian, Shukui Qin, David P. Ryan, B-Y Ryoo, Naoki Sasahira, Stacey Stein, John H. Strickler, N. C. Tebbutt
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
Lipika Goyal, Supriya K. Saha, Leah Y. Liu, Giulia Siravegna, Ignaty Leshchiner, Leanne G. Ahronian, Jochen K. Lennerz, Phuong Vu, Vikram Deshpande, Avinash Kambadakone, Benedetta Mussolin, Stephanie Reyes, Laura E. Henderson, Jiaoyuan Elisabeth Sun, Emily E. Van Seventer, Joseph M. Gurski, Sabrina Baltschukat, Barbara Schacher-Engstler, Louise Barys, Christelle Stamm, Pascal Furet, David P. Ryan, James R. Stone, A. John Iafrate, Gad Getz, Diana Graus Porta, Ralph Tiedt, Alberto Bardelli, Dejan Juric, Ryan B. Corcoran, Nabeel Bardeesy, Andrew X. Zhu
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
Matthew H. Kulke, Keith Stuart, Peter C. Enzinger, David P. Ryan, Jeffrey W. Clark, Alona Muzikansky, Michele Vincitore, Ann Michelini, Charles S. Fuchs
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R. Parikh, Emily E. Van Seventer, Giulia Siravegna, Anna Hartwig, Ariel Jaimovich, Yupeng He, Katie Kanter, Madeleine G. Fish, Kathryn Fosbenner, Benchun Miao, Susannah Phillips, John H. Carmichael, Nihaarika Sharma, Joy X. Jarnagin, Islam Baiev, Yojan S. Shah, Isobel J. Fetter, Heather A. Shahzade, Jill N. Allen, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Jon S. Dubois, Joseph W. Franses, Bruce J. Giantonio, Lipika Goyal, Samuel J. Klempner, Ryan David Nipp, Eric Roeland, David P. Ryan, Colin D. Weekes, Jennifer Y. Wo, Theodore S. Hong, Liliana Bordeianou, Cristina R. Ferrone, Motaz Qadan, Hiroko Kunitake, David L. Berger, Rocco Ricciardi, James C. Cusack, Victoria M. Raymond, AmirAli Talasaz, Genevieve M. Boland, Ryan B. Corcoran